Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial ; volume:22 ; number:1 ; day:23 ; month:3 ; year:2021 ; pages:1-12 ; date:12.2021
Respiratory research ; 22, Heft 1 (23.3.2021), 1-12, 12.2021
- Creator
-
Zheng, Jinping
Baldi, Simonetta
Zhao, Li
Li, Huiping
Lee, Kwan-Ho
Singh, Dave
Papi, Alberto
Grapin, Frédérique
Guasconi, Alessandro
Georges, George
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-021-01683-2
- URN
-
urn:nbn:de:101:1-2021050807345812765512
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zheng, Jinping
- Baldi, Simonetta
- Zhao, Li
- Li, Huiping
- Lee, Kwan-Ho
- Singh, Dave
- Papi, Alberto
- Grapin, Frédérique
- Guasconi, Alessandro
- Georges, George
- SpringerLink (Online service)
Other Objects (12)
Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation
Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2-Agonist
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro
Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids
Effects of corticosteroid plus long-acting beta2-agonist on the expression of PD-L1 in double-stranded RNA-induced lung inflammation in mice
Glucocorticoid hypersensitivity syndrome resulting from inhaled corticosteroid: a case report
A simple prediction tool for inhaled corticosteroid response in asthmatic children
The use of inhaled corticosteroid in preschool wheezers: what's the point today?
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy
Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation
Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2-Agonist
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro
Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids
Effects of corticosteroid plus long-acting beta2-agonist on the expression of PD-L1 in double-stranded RNA-induced lung inflammation in mice
Glucocorticoid hypersensitivity syndrome resulting from inhaled corticosteroid: a case report
A simple prediction tool for inhaled corticosteroid response in asthmatic children
The use of inhaled corticosteroid in preschool wheezers: what's the point today?
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial
Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy
Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation
Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2-Agonist
Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro
Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids
Effects of corticosteroid plus long-acting beta2-agonist on the expression of PD-L1 in double-stranded RNA-induced lung inflammation in mice
Glucocorticoid hypersensitivity syndrome resulting from inhaled corticosteroid: a case report
A simple prediction tool for inhaled corticosteroid response in asthmatic children
The use of inhaled corticosteroid in preschool wheezers: what's the point today?
Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial